Precision BioSciences (DTIL) News Today $5.91 +0.02 (+0.34%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$5.94 +0.02 (+0.42%) As of 02/21/2025 05:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period H.C. Wainwright Maintains Buy on Precision BioSciences StockFebruary 21 at 11:04 PM | uk.investing.comPrecision BioSciences (NASDAQ:DTIL) Given "Buy" Rating at HC WainwrightFebruary 21 at 3:43 AM | americanbankingnews.comPrecision BioSciences Touts Encouraging Initial Safety And Antiviral Activity Of Hepatitis B Treatment CandidateFebruary 19 at 3:01 PM | benzinga.comPrecision BioSciences announces initial results from ELIMINATE-B trialFebruary 19 at 8:14 AM | markets.businessinsider.comPrecision Bio gains on early Phase 1 data for Hep B candidateFebruary 19 at 8:14 AM | msn.comPrecision BioSciences Announces Initial Safety and Antiviral Activity of PBGENE-HBV in the ELIMINATE-B Clinical TrialFebruary 19 at 7:01 AM | businesswire.comMaxCyte Enters Strategic License Agreement with TG Therapeutics for Cell-Based Therapy DevelopmentFebruary 12, 2025 | quiverquant.comPrecision BioSciences Strengthens Senior Leadership Team to Drive Multiple In Vivo Gene Editing ProgramsJanuary 29, 2025 | businesswire.comPrecision BioSciences, Inc. (NASDAQ:DTIL) Insider Sells $49,274.73 in StockJanuary 23, 2025 | insidertrades.comPrecision Biosciences' general counsel sells shares worth $42,765January 23, 2025 | msn.comPrecision Biosciences CEO sells $172,033 in stockJanuary 23, 2025 | msn.comPrecision BioSciences shares soar on promising gene editing trial resultsJanuary 10, 2025 | investing.comAdvancements in Precision BioSciences’ Gene Editing Platform Bolster Buy RatingJanuary 10, 2025 | markets.businessinsider.comPrecision Bio rises after Phase 1/2 data for gene editing therapy in OTC deficiencyJanuary 10, 2025 | msn.comBMO Capital Upgrades Precision BioSciences (DTIL)January 10, 2025 | msn.comPrecision BioSciences' Gene Editing Platform Has Differentiated Mechanism, And Is Potentially Competitive: AnalystJanuary 10, 2025 | benzinga.comGeno J. Germano Acquires 3,605 Shares of Precision BioSciences, Inc. (NASDAQ:DTIL) StockJanuary 3, 2025 | insidertrades.comJohn Alexander Kelly Acquires 2,113 Shares of Precision BioSciences, Inc. (NASDAQ:DTIL) StockJanuary 1, 2025 | insidertrades.comPrecision BioSciences, Inc. (NASDAQ:DTIL) Director Melinda Brown Purchases 3,016 SharesDecember 31, 2024 | insidertrades.comPrecision BioSciences Receives Approval in Hong Kong to Expand PBGENE-HBV Phase 1 ELIMINATE-B Trial for the Treatment of Chronic Hepatitis BDecember 18, 2024 | tmcnet.comShort Interest in Precision BioSciences, Inc. (NASDAQ:DTIL) Rises By 11.8%Precision BioSciences, Inc. (NASDAQ:DTIL - Get Free Report) was the target of a large growth in short interest in November. As of November 15th, there was short interest totalling 239,900 shares, a growth of 11.8% from the October 31st total of 214,600 shares. Approximately 6.5% of the company's stock are short sold. Based on an average daily volume of 75,900 shares, the short-interest ratio is presently 3.2 days.December 2, 2024 | marketbeat.comPrecision BioSciences (NASDAQ:DTIL) Trading Up 3.6% - Time to Buy?Precision BioSciences (NASDAQ:DTIL) Trading Up 3.6% - Time to Buy?November 29, 2024 | marketbeat.comPrecision BioSciences to Participate in Upcoming November Investor ConferencesNovember 21, 2024 | businesswire.comPrecision BioSciences to present preclinical PBGENE-HBV dataNovember 15, 2024 | markets.businessinsider.comHC Wainwright Analysts Decrease Earnings Estimates for DTILPrecision BioSciences, Inc. (NASDAQ:DTIL - Free Report) - Equities research analysts at HC Wainwright lowered their FY2024 EPS estimates for shares of Precision BioSciences in a report released on Tuesday, November 5th. HC Wainwright analyst P. Trucchio now expects that the company will post earnNovember 7, 2024 | marketbeat.comPositive Outlook for Precision BioSciences: Buy Rating Affirmed Amid Promising Gene Editing DevelopmentsNovember 6, 2024 | markets.businessinsider.comPrecision BioSciences: Undervalued Gene Editing Innovator with Promising Financial and Clinical ProspectsNovember 6, 2024 | markets.businessinsider.comHC Wainwright Issues Optimistic Forecast for DTIL EarningsPrecision BioSciences, Inc. (NASDAQ:DTIL - Free Report) - Stock analysts at HC Wainwright increased their FY2027 earnings estimates for Precision BioSciences in a research note issued to investors on Tuesday, November 5th. HC Wainwright analyst P. Trucchio now anticipates that the company will poNovember 6, 2024 | marketbeat.comPrecision BioSciences, Inc. (NASDAQ:DTIL) CEO Sells $24,668.28 in StockNovember 6, 2024 | insidertrades.comPrecision BioSciences Reports Third Quarter 2024 Financial Results and Provides Business UpdateNovember 4, 2024 | businesswire.comPrecision BioSciences (DTIL) Set to Announce Earnings on MondayPrecision BioSciences (NASDAQ:DTIL) will be releasing earnings before the market opens on Monday, November 4, Zacks reports.October 30, 2024 | marketbeat.comPrecision BioSciences to Host Virtual Investor Event Highlighting PBGENE-HBV Preclinical Safety Data and Phase 1 Clinical Trial Plans on November 15, 2024October 28, 2024 | businesswire.comPrecision BioSciences presents preclinical data on ARCUS at ESGCTOctober 26, 2024 | markets.businessinsider.comPrecision BioSciences Presents Preclinical Data Highlighting the Capability of ARCUS for High-Efficiency Gene Editing Utilizing Homology-Directed Repair at the ESGCT 31st Annual CongressOctober 24, 2024 | businesswire.comPrecision BioSciences to Participate in Upcoming Longwood Boston CEO and Guggenheim Healthcare ConferencesOctober 21, 2024 | businesswire.comPrecision BioSciences, Inc. (NASDAQ:DTIL) Short Interest Down 7.1% in SeptemberPrecision BioSciences, Inc. (NASDAQ:DTIL - Get Free Report) saw a large drop in short interest in September. As of September 30th, there was short interest totalling 217,600 shares, a drop of 7.1% from the September 15th total of 234,300 shares. Based on an average daily volume of 41,500 shares, the short-interest ratio is presently 5.2 days. Currently, 5.9% of the company's stock are short sold.October 17, 2024 | marketbeat.comPrecision BioSciences to Present at the European Society of Gene & Cell Therapy (ESGCT) 31st Annual CongressOctober 16, 2024 | businesswire.comHow Artificial Intelligence, AI, Can Help Achieve Precision NutritionOctober 13, 2024 | forbes.comPrecision BioSciences to Present at the Upcoming H.C. Wainwright 5th Annual Viral Hepatitis Virtual ConferenceOctober 3, 2024 | businesswire.comMorrison joins third-tier UAE club PrecisionOctober 1, 2024 | ca.sports.yahoo.comPrecision Aviation Group Expands its Capabilities with Acquisitions of Icon Aerospace and Tag AeroOctober 1, 2024 | finance.yahoo.comPrecision BioSciences Submits First Clinical Trial Applications to Initiate Phase 1 Trial for PBGENE-HBV for the Treatment of Chronic Hepatitis BSeptember 30, 2024 | stockhouse.comPrecision BioSciences Reports CTA Submissions For PBGENE-HBV - Quick FactsSeptember 30, 2024 | markets.businessinsider.comOmnicom Precision Marketing Group Acquires LeapPoint For Undisclosed TermsSeptember 27, 2024 | markets.businessinsider.comPraxis Precision Medicines presents on ulixacaltamide Essential3 program at the Movement Disorders Society 2024 International CongressSeptember 26, 2024 | finance.yahoo.comPrecision Reloading Unveils New Peterson Brass Addition to Innovative Product LineupSeptember 24, 2024 | finance.yahoo.comPrecision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)September 20, 2024 | businesswire.comHogge Precision Parts Co, Inc. Celebrates 35 Years of Manufacturing in South Carolina with Cutting-Edge CNC MachinesSeptember 19, 2024 | finance.yahoo.comLandScan Secures Precision Agricultural Industry's First Digital Twin PatentSeptember 18, 2024 | finance.yahoo.comShort Interest in Precision BioSciences, Inc. (NASDAQ:DTIL) Decreases By 8.0%Precision BioSciences, Inc. (NASDAQ:DTIL - Get Free Report) was the recipient of a significant decline in short interest during the month of August. As of August 31st, there was short interest totalling 234,800 shares, a decline of 8.0% from the August 15th total of 255,200 shares. Based on an average trading volume of 36,400 shares, the days-to-cover ratio is presently 6.5 days. Currently, 6.3% of the company's stock are sold short.September 18, 2024 | marketbeat.com Get Precision BioSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for DTIL and its competitors with MarketBeat's FREE daily newsletter. Email Address DTIL Media Mentions By Week DTIL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DTIL News Sentiment▼0.290.60▲Average Medical News Sentiment DTIL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DTIL Articles This Week▼62▲DTIL Articles Average Week Get Precision BioSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for DTIL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Checkpoint Therapeutics News Solid Biosciences News MacroGenics News Organigram News Nkarta News ADC Therapeutics News Enanta Pharmaceuticals News Actuate Therapeutics News Nuvectis Pharma News Instil Bio News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DTIL) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Precision BioSciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Precision BioSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
